Thrivent Financial for Lutherans’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$621K Sell
27,036
-511
-2% -$11.7K ﹤0.01% 2041
2025
Q1
$799K Sell
27,547
-1,441
-5% -$41.8K ﹤0.01% 1854
2024
Q4
$1.08M Sell
28,988
-827
-3% -$30.7K ﹤0.01% 1850
2024
Q3
$1.45M Sell
29,815
-1,850
-6% -$89.8K ﹤0.01% 1672
2024
Q2
$1.27M Sell
31,665
-752
-2% -$30.1K ﹤0.01% 1708
2024
Q1
$1.42M Sell
32,417
-880
-3% -$38.6K ﹤0.01% 1669
2023
Q4
$2.06M Sell
33,297
-30,633
-48% -$1.89M ﹤0.01% 1350
2023
Q3
$2.94M Sell
63,930
-24,201
-27% -$1.11M 0.01% 1044
2023
Q2
$5.07M Buy
88,131
+50,772
+136% +$2.92M 0.01% 845
2023
Q1
$1.4M Sell
37,359
-1,310
-3% -$49.1K ﹤0.01% 1570
2022
Q4
$1.08M Sell
38,669
-852
-2% -$23.9K ﹤0.01% 1681
2022
Q3
$1.11M Buy
39,521
+2,581
+7% +$72.6K ﹤0.01% 1622
2022
Q2
$1.29M Buy
36,940
+6,946
+23% +$242K ﹤0.01% 1539
2022
Q1
$1.08M Buy
29,994
+10
+0% +$359 ﹤0.01% 1781
2021
Q4
$698K Buy
29,984
+89
+0.3% +$2.07K ﹤0.01% 2054
2021
Q3
$568K Sell
29,895
-90
-0.3% -$1.71K ﹤0.01% 2133
2021
Q2
$604K Sell
29,985
-63
-0.2% -$1.27K ﹤0.01% 2109
2021
Q1
$550K Sell
30,048
-229
-0.8% -$4.19K ﹤0.01% 2195
2020
Q4
$609K Sell
30,277
-42
-0.1% -$845 ﹤0.01% 2041
2020
Q3
$568K Buy
30,319
+2,091
+7% +$39.2K ﹤0.01% 1897
2020
Q2
$634K Sell
28,228
-489
-2% -$11K ﹤0.01% 1791
2020
Q1
$426K Buy
28,717
+1,434
+5% +$21.3K ﹤0.01% 1803
2019
Q4
$526K Sell
27,283
-109
-0.4% -$2.1K ﹤0.01% 1869
2019
Q3
$543K Sell
27,392
-175
-0.6% -$3.47K ﹤0.01% 1791
2019
Q2
$582K Buy
27,567
+1,141
+4% +$24.1K ﹤0.01% 1733
2019
Q1
$540K Buy
26,426
+2,027
+8% +$41.4K ﹤0.01% 1762
2018
Q4
$486K Sell
24,399
-663
-3% -$13.2K ﹤0.01% 1591
2018
Q3
$482K Buy
25,062
+440
+2% +$8.46K ﹤0.01% 1698
2018
Q2
$376K Buy
24,622
+1,750
+8% +$26.7K ﹤0.01% 1818
2018
Q1
$429K Buy
22,872
+572
+3% +$10.7K ﹤0.01% 1716
2017
Q4
$429K Buy
22,300
+440
+2% +$8.47K ﹤0.01% 1760
2017
Q3
$391K Buy
21,860
+250
+1% +$4.47K ﹤0.01% 1679
2017
Q2
$386K Buy
21,610
+1,460
+7% +$26.1K ﹤0.01% 1652
2017
Q1
$292K Buy
20,150
+710
+4% +$10.3K ﹤0.01% 1754
2016
Q4
$358K Buy
19,440
+400
+2% +$7.37K ﹤0.01% 1647
2016
Q3
$361K Buy
+19,040
New +$361K ﹤0.01% 1630